Tag Archives: Francoise Baylis
Risky Business: Genetic Discrimination & Insurance
Françoise Baylis discusses the response of the Canadian insurance industry to Bill S-201, An Act to prohibit and prevent genetic discrimination.
Human-Nonhuman Chimera Research in Canada
Françoise Baylis explains Canada’s regulatory framework for human-nonhuman chimera research and suggests that the proposed changes to the NIH guidelines to permit the funding of such research may have implications for Canadian research.
Pushing the 14-day limit on human embryo research
Françoise Baylis calls for a better alignment of the science and ethics of human embryo research.
Human Gene Editing: A Global Discussion
Françoise Baylis explains “On Human Gene Editing: International Summit Statement” to the participants at the American Association for the Advancement of Science 2016 Annual Meeting.
A Cautious Approach to Mitochondrial Replacement
Françoise Baylis comments on the US Institute of Medicine’s report on Mitochondrial Replacement.
Impact Ethics 